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Objective: Pulmonary overcirculation through a systemic-pulmonary shunt has been
one of the major causes of early death after the Norwood procedure. To avoid this
lethal complication, we constructed a right ventricle–pulmonary shunt in first-stage
palliation of hypoplastic left heart syndrome.
Methods: Between February 1998 and February 2002, 19 consecutive infants, aged
6 to 57 days (median, 9 days) and weighing 1.6 to 3.9 kg (median, 3.0 kg),
underwent a modified Norwood operation with the right ventricle–pulmonary artery
shunt. The procedure included aortic reconstruction by direct anastomosis of the
proximal main pulmonary artery and a nonvalved polytetrafluoroethylene shunt
between a small right ventriculotomy and a distal stump of the main pulmonary
artery. The size of the shunt used was 4 mm in 5 patients and 5 mm in 14.
Results: All patients were managed without any particular manipulation to control
pulmonary vascular resistance. There were 17 survivors (89%), including 3 patients
weighing less than 2 kg. Two late deaths occurred due to obstruction of the right
ventricle–pulmonary artery shunt. Thirteen patients underwent a stage II Glenn
procedure after a mean interval of 6 months, with 2 hospital deaths. To date, a stage
III Fontan procedure has been completed in 4 patients. Overall survival was 62%
(13/19). Right ventricular fractional shortening at the last follow-up (3-48 months
after stage I) ranged from 26% to 43% (n  13, mean, 33%).
Conclusion: Without delicate postoperative management to control pulmonary vas-
cular resistance, the modified Norwood procedure using the right ventricle–pulmo-
nary shunt provides a stable systemic circulation as well as adequate pulmonary
blood flow. This novel operation may be particularly beneficial to low-birth-weight
infants with hypoplastic left heart syndrome.
Survival of infants born with hypoplastic left heart syndrome (HLHS)has steadily improved since Norwood and colleagues1 first reported amultistaged reconstructive approach in 1983. The Norwood procedure(stage I palliation) consists of atrial septectomy, reconstruction of theascending aorta and aortic arch, and placement of a systemic-pulmo-nary shunt. Despite successful reconstructive surgery, most deaths
occur in the first 24 to 48 hours after surgery due to hemodynamic instability
secondary to the unpredictable rapid fall in pulmonary vascular resistance.2,3 Over
the past decade, efforts to achieve a balanced circulation during the early postop-
erative period have focused on limiting pulmonary blood flow and improving
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systemic blood flow. These measures have included reduc-
tion in the size of the systemic-pulmonary shunts,3,4 venti-
lator manipulations according to delicate blood gas analy-
ses,3,5 use of hypoxic admixtures,6,7 and systemic
vasodilators.3,6,8 Although several experienced centers have
achieved operative survival for the Norwood procedure
between 63% and 94%,3-5,9-11 this procedure still remains a
challenging step with high mortality for many institutions
with a smaller surgical volume.12,13
To avoid hemodynamic instability associated with the
systemic-pulmonary shunt, we constructed a nonvalved
polytetrafluoroethylene (PTFE) shunt between the right
ventricle and the pulmonary artery (RV-PA shunt) in first-
stage palliation of HLHS. In this article we describe our
entire experience with the RV-PA shunt, developing surgi-
cal techniques, and early- to medium-term results of this
novel surgical approach.
Patients and Methods
Patient Population
Between February 1998 and February 2002, 19 consecutive infants
(11 boys and 8 girls) with HLHS or a variant underwent a modified
Norwood procedure using an RV-PA shunt. The diagnosis was
made antenatally in 3 patients. Two were preterm infants (37
weeks’ gestational age). Three patients had ductal shock before
admission. On arrival at Okayama University Hospital, all patients
underwent detailed echocardiography. Fifteen patients had classic
HLHS, including aortic atresia or stenosis, mitral atresia or steno-
sis with a poorly developed left ventricle, normally related great
arteries, and an intact ventricular septum. The remaining 4 patients
had variants of HLHS with left ventricular and aortic arch hyp-
oplasia: 2 had a double-outlet right ventricle with aortic and
subaortic stenoses, 1 had aortic and mitral stenoses with a ventric-
ular septal defect, and 1 had aortic atresia with type B interrupted
aortic arch and a ventricular septal defect. Associated anomalies
included a persistent left superior vena cava in 2 patients and an
aberrant right subclavian artery in 1. The diameters of the ascend-
ing aorta ranged from 1.6 to 7.6 mm (mean, 3.6 mm; median, 3.0
mm) and were 2 mm or less in 5 patients. Right ventricular
fractional shortening ranged from 24% to 43% (mean, 33%; me-
dian, 32%). Tricuspid regurgitation documented by color flow
Doppler echocardiography was absent in 3 patients, mild in 9,
moderate in 6, and severe in 1.
Age at operation ranged from 6 to 57 days (mean, 15 days;
median, 9 days). Weight at operation ranged from 1.6 to 3.9 kg
(mean, 2.8 kg; median, 2.8 kg) and 3 patients weighed less than 2.0
kg. Twelve patients underwent mechanical ventilation before the
operation, and all but 1 patient received an infusion of alprostadil
(prostaglandin E1).
Operative Procedure
Arterial blood pressure monitoring lines were placed in the right
radial artery and femoral artery in each patient preoperatively.
Through a midline sternotomy, the thymus gland was excised. The
aortic arch, its branches, and the ductus arteriosus were dissected
out. Dual arterial cannulas were inserted into the ductus arteriosus
and into a 3.5-mm PTFE tube (Gore-Tex, W. L. Gore & Associ-
ates, Inc, Flagstaff, Ariz) that was anastomosed to the innominate
artery. After insertion of a venous cannula into the right atrium,
cardiopulmonary bypass was commenced at a flow rate of 150 to
180 mL/min per kilogram (Figure 1). The branch right and left
pulmonary arteries were temporarily occluded with tourniquets
and systemic cooling was initiated.
Before establishment of cardiopulmonary bypass, the shunt
material was prepared on another table as follows. In case of a
5-mm shunt, a 5-mm PTFE tube was cut into an appropriate length
as a shunt tube. A cuff for an anastomosis to the distal end of the
main pulmonary artery was tailored by vertically opening a piece
of the same PTFE tube. The center of the cuff was punched out in
5-mm diameter, and the tube was anastomosed to this opening with
a 8-0 PTFE suture (rectangle in Figure 2).
During the cooling phase, the isthmus was ligated and divided
to obtain a better operative field. After division of the duct prox-
imal to the cannulation site, the descending thoracic aorta was
extensively mobilized by blunt dissection as far distally as possi-
ble. The main pulmonary artery was transected just proximal to the
bifurcation, and the PTFE cuff was anastomosed to the distal
stump of the main pulmonary artery with an 8-0 PTFE suture
(Figure 2). An appropriate site of ventriculotomy for the RV-PA
shunt, which was 1.5 to 2 cm below the pulmonary valve, was
marked on the right ventricular outflow tract. Although we re-
paired the distal end of the main pulmonary artery with an autol-
ogous pericardial patch and anastomosed the shunt tube onto this
patch in the first 6 patients, we abandoned this procedure because
of intractable bleeding and the high incidence of late obstruction at
the anastomotic site.
At a nasopharyngeal temperature of less than 22°C, the de-
scending aorta was clamped. After removal of the perfusion can-
Figure 1. A 3-mm PTFE tube was anastomosed to the innominate
artery. Dual arterial cannulas were inserted into the PTFE tube
and the ductus arteriosus.
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nula from the duct, all duct tissue was excised from the descending
aorta. The left carotid artery and left subclavian artery were snared.
Isolated cerebral and myocardial perfusion was established by
placing a clamp just distal to the innominate artery.14,15 With the
heart beating, the aortic arch was opened inferiorly and the back
wall of the descending aorta was anastomosed to the posterior wall
of the aortic arch.
At this stage, cold crystalloid cardioplegic solution (30 mL/kg)
was administered over 3 minutes either from the aortic root or
from a side port of the arterial cannula during temporary total
circulatory arrest. The innominate artery was snared proximal to
the perfusion site, and the clamp on the arch was removed. Car-
diopulmonary bypass was resumed for isolated cerebral perfusion
through the innominate artery. The aortic arch reconstruction was
carried out by means of Brawn’s modification.3 The opening of the
aortic arch was extended down into the ascending aorta to the level
of the transected end of the main pulmonary artery. The proximal
main pulmonary artery was directly anastomosed to the transverse
arch and the opened-out ascending aorta (Figure 3).
After completion of aortic arch reconstruction, the circulation
was again arrested. The venous cannula was removed from the
right atrium. The atrial septum was excised, working through the
purse-string suture on the atrial appendage. A small right ventric-
ulotomy was made at the previously marked site (Figure 3). To
prevent late obstruction at the shunt anastomosis, it was important
to slice off a piece of ventricular muscle underlying the ventricu-
lotomy. Cardiopulmonary bypass was reinstituted, and all snares
were removed. The RV-PA shunt was placed to the left of the
neoaorta in all patients and was anastomosed to the right ventric-
ulotomy during rewarming (Figure 4). The size of the RV-PA
shunt used was 4 mm in 5 patients weighing less than 2.5 kg and
5 mm in the other patients. The mean total circulatory arrest time
was 6 minutes (range, 0 to 17 minutes), the mean myocardial
ischemic time was 47 minutes (range, 27 to 94 minutes), and the
mean descending aortic clamp time was 51 minutes (range, 10 to
99 minutes). All patients could be weaned from cardiopulmonary
bypass without any difficulties.
Postoperative Management
Postoperative management of patients undergoing the modified
Norwood operation with the RV-PA shunt was basically the same
as that for neonates undergoing other types of operations. Delayed
sternal closure was performed in all but 1 patient on postoperative
Figure 3. The descending aorta was anastomosed to the posterior
wall of the aortic arch. The entire aortic arch and ascending
aorta were reconstructed by direct anastomosis of the proximal
main pulmonary artery. A small right ventriculotomy was made in
the outflow tract for proximal anastomosis of the RV-PA shunt.
Figure 4. After completion of aortic reconstruction and atrial
septectomy, proximal anastomosis of the RV-PA shunt was per-
formed with the heart beating.
Figure 2. A PTFE tube was previously anastomosed to a PTFE cuff
(rectangle). The cuff was anastomosed to the distal end of the
main pulmonary artery.
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days 2 to 7 (median, 4 days). The inotropic drugs used were
dopamine 5 to 10 g/kg per minute, epinephrine 0.1 g/kg per
minute, and calcium chloride 0.25 mmol/h. Ventilator settings
were usually constant, at a rate of 20 breaths/min, a positive
end-expiratory pressure of 5 cm H2O, and peak inspiratory pres-
sures of 18 to 20 cm H2O, except in case of airway problems. The
inspired oxygen fraction was adjusted to keep arterial oxygen
saturations higher than 75%. Systemic and pulmonary vasodilators
to control vascular resistance were not used in any of the 19
patients.
Echocardiographic Assessment and Late Management
To evaluate diastolic reverse flow and the pressure gradient across
the nonvalved RV-PA shunt, sequential Doppler echocardiography
was performed in 7 patients at postoperative months 1 and 4 before
stage II palliation. A spectral time-velocity display was obtained at
the middle point of the RV-PA shunt. The velocity-time integrals
of reverse and forward flow were measured by tracing the curves
above and below the spectral baseline, respectively. The velocity-
time integrals of the diastolic reverse flow were divided by the
velocity-time integrals of systolic forward flow for calculation of
the Doppler flow reversal ratio. Elective cardiac catheterization
was carried out 3 to 4 months after stage I palliation. Results are
expressed as mean SD. The Wilcoxon signed-rank test was used
for comparison of data between postoperative months 1 and 4.
When patients presented with progressive desaturation, the
stage II bidirectional Glenn (BDG) procedure was performed with
or without cardiopulmonary bypass. The RV-PA was left open as
an additional pulmonary blood supply. The stage III Fontan pro-
cedure was performed at approximately 2 years of age. A lateral
tunnel cavopulmonary connection was constructed by means of a
PTFE patch or a right atrial flap without fenestration.
Results
Without any particular ventilatory manipulation, hemody-
namic instability never occurred in any of the 19 patients.
Transcutaneous oxygen saturations were maintained be-
tween 75% and 85%. Diastolic blood pressures remained
above 40 mm Hg with pulse pressures of 20 to 30 mm Hg.
There were 17 hospital survivors (89%), including 3 pre-
mature infants weighing less than 2 kg. One patient died
from sudden cardiac arrest on the next day and the other
from septicemia after 2 weeks. There were 2 late deaths
among the first 4 patients; both died from severe hypoxemia
due to obstruction of the RV-PA shunt (1 at 3 months and
1 at 4 months after surgery).
The mean Doppler flow reversal ratio in the RV-PA
shunt decreased from 0.28  0.03 at 1 postoperative month
to 0.16  0.02 at 4 months (n  7, P  .027), while the
mean pressure gradient across the shunt increased from 34
 10 mm Hg to 58  14 mm Hg (P  .018). At the same
time, the mean transcutaneous oxygen saturation decreased
from 82  7% to 70  8% (P  .018). Cardiac catheter-
ization and cineangiography before stage II palliation (Fig-
ure 5) demonstrated that the mean pulmonary artery pres-
sure was 11  2 mm Hg (n  13; range, 9 to 15 mm Hg)
and the mean PA index16 measured was 215  96 (range,
117 to 458).
Thirteen patients underwent the BDG at a median age of
6 months (range, 3 to 9 months), and 6 of them required
instrumental dilation (3-mm or 4-mm Hegar dilator) for
pulmonary artery stenosis near the RV-PA shunt. There
were 2 hospital deaths, one from viral pneumonia and the
other from progressive hypoxemia. Currently 2 patients are
awaiting the BDG, 7 are awaiting the Fontan, and 4 have
undergone the Fontan, with an overall survival of 62%. The
last echocardiographic evaluation was performed in 13 sur-
vivors at a median of 16 months (range, 3-48 months) after
the modified Norwood procedure. Right ventricular frac-
tional shortening ranged from 26% to 43% (mean, 33%;
median, 31%). Tricuspid regurgitation was absent in 5 pa-
Figure 5. Frontal view at end-systole (left) and lateral view at end-diastole (right) of a right ventriculogram 4
months after stage I palliation, showing an unobstructed RV-PA shunt.
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tients, mild in 5, and moderate in 3 whose regurgitation
before stage I palliation was absent, moderate, and severe,
respectively.
Discussion
The RV-PA shunt to reestablish pulmonary blood supply in
stage I palliation for HLHS was first introduced by Nor-
wood and colleagues in 1981.17 The shunt materials they
used were relatively large for neonates; 8-mm nonvalved
PTFE tubes in 2 patients and 12-mm valved conduits in 2.
These patients all died within 11 hours after surgery either
from excessive pulmonary blood flow or from right ventric-
ular failure.2 Kishimoto and coworkers18 in Japan revived
the RV-PA shunt using a xenopericardial valved conduit,
and they reported stable postoperative hemodynamics with
a high diastolic blood pressure. Their findings stimulated us
to attempt an RV-PA shunt, but with a small nonvalved
PTFE conduit in stage I palliation. Although our institu-
tional results of reconstructive surgery for HLHS before
1998 included a survival of 53% (17/33 classic Norwood
over 6 years), we could achieve a stage I survival of 89%
with the application of the RV-PA shunt and subsequently
reach an overall survival of 62%.
The results of the present study have clearly shown
differences in postoperative hemodynamics between the
systemic-pulmonary shunt and the RV-PA shunt. With-
out delicate manipulation of systemic and pulmonary
vascular resistance, the RV-PA shunt using a nonvalved
PTFE conduit provides a stable systemic circulation as
well as adequate pulmonary blood flow after stage I
palliation. Although we have not determined an optimal
size for the RV-PA shunt, our current choice of shunt is
a 5-mm PTFE tube for patients weighing more than 2 kg
and a 4-mm tube for patients less than 2 kg. These sizes
of shunts are almost equivalent to 50% of the predicted
normal size of the main pulmonary artery.19 From an
anatomic point of view, therefore, HLHS hearts after
aortic reconstruction with the main pulmonary artery and
placement of an RV-PA shunt are similar to univentricu-
lar hearts with pulmonary stenosis. In this anatomic set-
ting, pulmonary blood flow is limited by the size of the
shunt, and systemic circulation, including coronary per-
fusion, theoretically cannot be compromised by changes
in pulmonary vascular resistance. Our hypothesis was
confirmed in other type of single-ventricle physiology as
well. We have applied the RV-PA shunt in 2 newborn
infants with heterotaxy syndrome, pulmonary atresia, and
infracardiac type total anomalous pulmonary venous con-
nection. Postoperative hemodynamics of these patients
was also stable and both survived.
Excellent hemodynamics provided by the RV-PA
shunt is particularly beneficial for low-birth-weight in-
fants undergoing stage I palliation. Reported survival for
patients weighing less than 2.5 kg after the Norwood
procedure is still high (45% to 51%).20,21 Even the small-
est 3-mm PTFE tube may be too large to limit pulmonary
blood flow through the systemic-pulmonary shunt in this
subgroup of patients. Because of the lack of suitably
sized material, a standard Blalock-Taussig shunt has been
the alternative method for very-low-weight infants.4,22 In
the present series, the 3 infants weighing less than 2 kg
received a 4-mm RV-PA shunt and all survived without
any hemodynamic instability or right ventricular dys-
function.
The effects of a right ventriculotomy for the placement
of the RV-PA shunt on systemic right ventricular function
are of great concern. During early- to medium-term follow-
up, right ventricular function evaluated by echocardiogra-
phy was acceptable, and its fractional shortening in the 4
patients who had undergone the Fontan procedure was
higher than 30%. In addition, ventricular arrhythmias were
not found in any of the survivors. Another concern is related
to the degree of flow reversal in the nonvalved RV-PA
shunt. Doppler echocardiography demonstrated the greatest
reversal flow ratio within 1 month after surgery, but all
patients tolerated this volume overload well, maintaining
reasonable oxygen saturation levels.
The lessons learned from 4 years of experience with the
modified Norwood procedure using the RV-PA shunt are
twofold. First, the nonvalved PTFE RV-PA shunt becomes
obstructive with time, particularly from 3 months after
surgery, as evidenced by the decrease in oxygen saturation
and increase in the pressure gradient across the shunt. As 2
patients in the early series died from progressive shunt
obstruction after hospital discharge, we are now very careful
when patients’ oxygen saturations start decreasing. We have
not used a larger shunt, such as 6-mm or 8-mm PTFE tube,
because effect of a larger ventriculotomy on ventricular
function is unclear. Second, pulmonary artery growth in
patients who received the RV-PA shunt is not as well as in
those who had a systemic-to-pulmonary shunt, indicating
that the RV-PA shunt provides less pulmonary blood flow
than the systemic-to-pulmonary shunt. However, resultant
lower pulmonary vascular resistance made the BDG and
subsequent Fontan procedures possible, even in patients
with a PA-index of 200 or less.
In conclusion, the RV-PA shunt in stage I palliation
provides stable hemodynamics and fine control of systemic
and pulmonary resistance without extensive postoperative
medical intervention. This novel procedure may be partic-
ularly beneficial to low-birth-weight infants with HLHS.
However, it is cautioned that the RV-PA shunt becomes
obstructive with time. We believe that improvement in
survival for infants undergoing stage I palliation for HLHS
would be reproducible for many less experienced surgeons
with application of the RV-PA shunt.
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Discussion
Dr S. Bert Litwin (Milwaukee, Wis). Dr Sano and his col-
leagues have presented data on 19 infants who underwent Nor-
wood palliation for HLHS, and they achieved an excellent 89%
hospital survival. Their surgical technique differs from that used
by most surgeons in the current era with pulmonary blood flow
received from a direct RV-PA shunt rather than a systemic–
pulmonary artery shunt.
Placing the pulmonary and systemic circulations in parallel
rather than in series may have certain advantages. Imbalance of
pulmonary and systemic blood flows is the leading cause of
morbidity and mortality after the Norwood procedure. Most cen-
ters accomplish balance by manipulating vascular resistance. Dr
Sano’s patients required no such manipulation, which resulted in a
more predictable postoperative recovery.
The pulmonary bed was not subjected to nor dependent on
diastolic flow, and there should be less change in pulmonary blood
flow with pulmonary hypertensive crises or during resuscitation in
the presence of low cardiac output or after a cardiac arrest.
There may, however, be deleterious effects with an additional
volume load on the ventricle from regurgitation through the
RV-PA shunt. This may result in ventricular dilatation and tricus-
pid regurgitation. A number of patients presented here had tricus-
pid regurgitation after stage I, although the incidence was less than
preoperatively.
Dr Sano used larger 4- and 5-mm shunts and achieved balanced
pulmonary and systemic circulations without overperfusion of the
lungs. With larger shunts, less precision in gauging the size of the
shunt should be needed and this might avoid some early reopera-
tions for shunt change. Also, with a larger shunt, there should be
a greater shunt longevity as well as a slower and more predictable
shunt closure pattern. Such was not the case here in that 2 patients
died late due to acute shunt closure and 7 others studied by
echocardiography showed progressive shunt narrowing within 4
months.
I have a few questions.
Did the shunt regurgitation cause an increase in tricuspid re-
gurgitation in any patient and did you have to repair the tricuspid
valve at stage II in any patient?
Why did you leave the shunt patent, as stated in your manu-
script, after stage II? Were the 2 deaths after stage II related to
residual shunt patency or tricuspid regurgitation? Did any patients
after stage II have prolonged pleural drainage?
In the manuscript you state that your survival was 53% before
you used the RV-PA shunt and 89% with the RV-PA shunt. Did
you analyze the two groups for other factors that might have
accounted for your improved survival?
Dr Sano, your presentation was clear, your manuscript was well
written, and you have made a compelling argument for the use of
the RV-PA shunt in the Norwood procedure. This information
should be useful to surgeons in considering various options for
babies with HLHS, and I thank you for bringing this information
to this meeting.
Dr Sano. Thank you, Dr Litwin, for your comments.
Regarding your first question, we also were concerned about
volume loading due to shunt regurgitation through a nonvalved
conduit. This was also why we used a 4-mm PTFE graft rather than
a 5-mm graft initially.
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